文献速递免疫规划卫生政策与健康促进营养与食品安全

澳大利亚公众对人类与动物mRNA疫苗接种的态度:一项横断面调查

Australians' attitudes to mRNA vaccination in humans and animals: A cross-sectional survey.
PubMed 文献 · Vaccine · 2026-07-07

该研究对澳大利亚18岁以上公众开展横断面在线调查,描述其对mRNA疫苗与传统疫苗的态度差异、未来传染病应急时接种mRNA疫苗的意愿,以及对接种mRNA疫苗的牛所产牛肉和牛奶的消费态度。结果显示公众对疫苗接种总体支持度高,但对传统疫苗的支持强于mRNA疫苗,应急接种意愿与自愿性、理解和较高信任相关,对动物接种mRNA疫苗了解不足,对相关肉奶产品态度不一。

要点

  • 公众对传统疫苗的支持强于对mRNA疫苗的支持,后者理解不足。
  • 未来应急时接种mRNA疫苗的意愿与自愿性、理解和较高信任相关。
  • 对动物mRNA疫苗接种了解不足,对相关牛肉和牛奶消费态度不一。

核心结论

  • 疫苗制造商和公共卫生及动物卫生政策制定者应预期公众对mRNA疫苗及接种mRNA疫苗的牛所产肉奶产品接受度可能较低。
  • 新疫苗技术的科学热情必须与公众接受度相匹配,才能实现最佳使用。

研究设计与样本

  • 横断面、自填式在线调查,对象为澳大利亚18岁以上公众。
  • 对全部变量进行描述性统计分析,变量间关联采用卡方检验。
  • 将与未来接种mRNA疫苗意愿相关且p<0.25的变量纳入后退逐步logistic回归模型,显著性水平p<0.05;缺失数据不纳入多变量分析。
  • 对开放文本回答进行情感和主题分析。

主要发现

  • 疫苗接种支持度高,但对传统制造疫苗的支持强于对mRNA疫苗的支持,mRNA疫苗未被充分理解。
  • 应急时对mRNA疫苗接种的接受与自愿性、理解和较高信任相关。
  • 动物疫苗接种未被充分理解,对来自接种mRNA疫苗的牛的肉奶产品消费支持度不一。

关键数值与推荐

  • 变量纳入多变量模型的标准为与未来接种mRNA疫苗意愿相关的显著性水平p<0.25。
  • 后退逐步logistic回归模型使用显著性水平p<0.05。

临床怎么用

  • 公共卫生与动物卫生政策制定者应预先评估公众对mRNA疫苗及相关动物产品的接受度。
  • 提升公众对mRNA疫苗技术的理解与信任,可能有助于应急接种意愿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: COVID-19 vaccines using messenger RNA (mRNA) technologies have been commercially available since 2021. The platform is being used to develop new vaccines for people and animals, but not without controversy. Pockets of public resistance to COVID-19 vaccines has contributed to the slowing of mRNA research in some countries (e.g. the United States), while others (e.g. Australia) are poised to approve new vaccines. We set out to understand 1) whether Australians express different attitudes to mRNA vaccines compared to conventional vaccines, 2) about willingness to be vaccinated with mRNA vaccines in the event of a future infectious disease emergency, and 3) attitudes towards consumption of beef and milk from mRNA vaccinated cattle. METHODS: Cross-sectional, self-administered online survey of the Australian public aged over 18. We performed descriptive statistics analyses on all variables. Associations between variables was assessed using chi-squared tests. Variables associated with willingness to have an mRNA vaccine in future with a significance level of p < 0.25 were entered into a backward stepwise logistic regression model, using a significance level of p < 0.05. Missing data was not included in multivariate analyses. Sentiment and thematic analyses conducted on open text responses. RESULTS: Support for vaccination was high, but there was stronger support for traditionally manufactured vaccines than for mRNA-based vaccines, which are not well understood. Acceptance of mRNA vaccination in an emergency is associated with voluntariness, understanding and higher trust. Animal vaccination is not well understood and support for consumption of meat and milk products from mRNA vaccinated cattle was mixed. CONCLUSIONS: Vaccine manufacturers, public health and animal health policy makers should anticipate the potential for lower public acceptance of mRNA vaccines and milk and meat products from mRNA vaccinated cattle. Enthusiasm for scientific development of new vaccine technologies must be matched by enthusiastic public acceptability if new vaccines are to be optimally used.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Williams J, Degeling C, Donovan L, et al. Australians' attitudes to mRNA vaccination in humans and animals: A cross-sectional survey. Vaccine. 2026. PMID: 42413319. doi:10.1016/j.vaccine.2026.128907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。